NAFDAC Good Manufacturing Practice Guidelines for Pharmaceutical Products 2016
Ministry of Industry, Trade and Investment, National Agency for Food and Drug Administration and Control, Nigeria
Good manufacturing practice (GMP) is that part of quality assurance that ensures that pharmaceutical products are consistently produced and controlled to the quality standards appropriate to their intended use and as required by their marketing authorizations. These guidelines apply to pharmaceutical, biological, and veterinary products and they are intended to help all stakeholders comply with the provisions of the National Agency for Food and Drug Administration and Control (NAFDAC) good manufacturing Practice Regulations for pharmaceutical products.
You are viewing a previous version. Click here to view the current version.
Read in full screenProcess Flow
Department of Pharmacovigilance and Post Marketing Surveillance ⬤
Office of the Director General NAFDAC ⬤
Office of the Permanent Secretary, Ministry of Health ⬤
Office of the Minister of State for Health ⬤
Office of the Minister of Health ⬤
Federal Executive Council ⬤
NAFDAC Good Manufacturing Practice Guidelines for Pharmaceutical Products 2016 Current Version
January 2022
Good manufacturing practice (GMP) is that part of quality assurance that ensures that pharmaceutical products are consistently produced and controlled to the quality standards appropriate to their intended use and as required by their marketing authorizations. These guidelines apply to pharmaceutical, biological, and veterinary products and they are intended to help all stakeholders comply with the provisions of the National Agency for Food and Drug Administration and Control (NAFDAC) good manufacturing Practice Regulations for pharmaceutical products.
Thank you for requesting an expert analysis
A member of our team will review your request and reply back to the email address on file.